Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

HANSOH Aktie

 >HANSOH Aktienkurs 
4.62 EUR    +3.6%    (Tradegate)
Ask: 4.66 EUR / 635 Stück
Bid: 4.48 EUR / 663 Stück
Tagesumsatz: 205 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
HANSOH Aktie über LYNX handeln
>HANSOH Performance
1 Woche: +2,2%
1 Monat: +17,0%
3 Monate: +14,9%
6 Monate: +60,4%
1 Jahr: +99,1%
laufendes Jahr: +115,9%
>HANSOH Aktie
Name:  HANSOH PHARMACEUTICAL GROUP
Land:  China
Sektor:  Gesundheit
ISIN/ Wkn:  KYG549581067 / A2PLRC
Symbol/ Ticker:  3KY (Frankfurt)
Kürzel:  FRA:3KY, ETR:3KY, 3KY:GR
Index:  -
Webseite:  https://www.hansoh.cn/en/
Profil:  Hansoh Pharmaceutical Group Co., Ltd. is a leading..
>Volltext..
Marktkapitalisierung:  27031.51 Mio. EUR
Unternehmenswert:  23832.85 Mio. EUR
Umsatz:  1556.45 Mio. EUR
EBITDA:  571.57 Mio. EUR
Nettogewinn:  563.73 Mio. EUR
Gewinn je Aktie:  0.09 EUR
Schulden:  14 Mio. EUR
Liquide Mittel:  531.79 Mio. EUR
Operativer Cashflow:  659.3 Mio. EUR
Bargeldquote:  7.53
Umsatzwachstum:  -1.7%
Gewinnwachstum:  -8.64%
Dividende je Aktie:  0.04 EUR
Dividendenrendite:  0.91%
Dividendenschätzung:  0.91%
Div. Historie:  22.09.25 - 0.025577905€
03.07.25 - 0.0149425315€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  HANSOH
Letzte Datenerhebung:  07.12.25
>HANSOH Kennzahlen
Aktien/ Unternehmen:
Aktien: 6053.96 Mio. St.
Frei handelbar: 20.29%
Leerverk. Aktien: -
Rückkaufquote: -0.01%
Mitarbeiter: 8989
Umsatz/Mitarb.: 0.16 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: 9.95%
Bewertung:
KGV: 48.1
KGV lG: 42.75
KUV: 16.85
KBV: 7.27
PEG-Ratio: 26.91
EV/EBITDA: 41.7
Rentabilität:
Bruttomarge: 91%
Gewinnmarge: 36.22%
Operative Marge: 33.83%
Managementeffizenz:
Gesamtkaprendite: 14.23%
Eigenkaprendite: 16.09%
>HANSOH Peer Group

Es sind 101 Aktien bekannt.
 
08.12.25 - 04:15
HANSOH PHARMA Ameiles Two New Indications Included in Chinas NRDL (AAStocks)
 
HANSOH PHARMA (03692.HK) announced that two new indications of Ameile, an innovative drug of the Group, have been successfully added to the new National Reimbursement Drug List (2025 Version) (2025 NRDL), and all indications of Saint Luolai and Hengmu, innovative drugs of the Group, have been renewed in the 2025 NRDL. The new NR......
05.12.25 - 09:30
Full-day Takeaway: HSI Closes at 26,085, Up 149 pts; HSTI Closes at 5,662, Up 47 pts; PING AN Up over 6%; HANSOH PHARMA, ENN ENERGY, SINOTRUK Hit New Highs; Market Turnover Rises (AAStocks)
 
At close, HSI rose 149 pts or 0.6% to 26,085. HSTI rose 47 pts or 0.8% to 5,662. HSCEI gained 91 pts or 1.0% to 9,198. Market turnover reached $210.47 billion.Active Heavyweights:PING AN (02318.HK) closed at $60.45, up 6.7%XIAOMI (01810.HK) closed at $42.78, up 1.9%MEITUAN (03690.HK) closed at $99.05, up 1%CCB (00939.HK) closed ......
27.11.25 - 09:15
Full-day Takeaway: HSI Closes at 25,945, Up 17 pts; HSTI Closes at 5,598, Down 20 pts; POP MART Up over 6%; HANSOH PHARMA, MTR CORPORATION, LEE & MAN PAPER, GLOBAL NEW MAT, ND PAPER Hit New Highs; Market Turnover Rises (AAStocks)
 
At close, HSI rose 17 pts or 0.1% to 25,945. HSTI dropped 20 pts or 0.4% to 5,598. HSCEI gained 2 pts or 0.0% to 9,164. Market turnover reached $204.73 billion.Active Heavyweights:BABA (09988.HK) closed at $150.6, down 2.7%XIAOMI (01810.HK) closed at $41.1, up 2.5%TENCENT (00700.HK) closed at $611.5, down 1.3%HKEX (00388.HK) clo......
24.11.25 - 09:15
Full-day Takeaway: HSI Up 496 pts; HSTI Up 150 pts; BABA Up over 4%; HANSOH PHARMA, EVERG SERVICES Hit New Highs; Market Turnover Rises (AAStocks)
 
At close, HSI rose 496 pts or 2.0% to 25,716. HSTI rose 150 pts or 2.8% to 5,545. HSCEI gained 159 pts or 1.8% to 9,079. Market turnover reached $302.64 billion.Active Heavyweights:BABA (09988.HK) closed at $154.5, up 4.7%MEITUAN (03690.HK) closed at $98.15, up 2.7%TENCENT (00700.HK) closed at $624.5, up 2.4%XIAOMI (01810.HK) cl......
03.11.25 - 09:30
Research: JPM Names AKESO/ HANSOH PHARMA/ WUXI APPTEC as Top Picks; Pharma Pullback Provides Tailwinds for Next Yr (AAStocks)
 
Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...
17.10.25 - 13:54
Roche licenses cancer candidate from China’s Hansoh Pharma (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
17.10.25 - 09:24
Roche erhält Lizenzrechte für Krebskandidaten der chinesischen Hansoh (Cash)
 
Pharmazie - Roche investiert in chinesische Krebsforschung....
17.10.25 - 07:12
Hansoh and Leads Biolabs clinch US$2.5 billion in global drug licensing deals (SCMP)
 
Two Chinese drug developers have signed licensing deals that could yield as much as US$2.5 billion in performance-based payments, underscoring growing international confidence in China's life sciences sector. Hansoh Pharmaceutical Group has agreed to license global rights – excluding mainland China, Hong Kong, Macau and Taiwan – to develop and market a colon cancer drug candidate to F Hoffmann-La Roche, a unit of Swiss-based biotech giant Roche. Hansoh, a major psychotropic and cancer drugs......
30.09.25 - 06:00
Research: UBS Downgrades CSPC PHARMA/ KELUN PHARM to Neutral, Changes Sector Top Pick to HANSOH PHARMA (AAStocks)
 
Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...
30.09.25 - 05:30
Research: UBS Ratings/ TPs on CN Pharmas (Table) (AAStocks)
 
Stock | Rating | TP (HKD)HENGRUI PHARMA (01276.HK) | Buy | 97.8 HANSOH PHARMA (03692.HK) | Buy | 48.2 SINO BIOPHARM (01177.HK) | Buy | 12.23SBIO (01530.HK) | Buy | 41 CSPC PHARMA (01093.HK) | Buy -> Neutral | 10 SIMCERE PHARMA (02096.HK) | Buy | 16.3HENGRUI PHARMA (600276.SH) | Buy | RMB78.6 HUADONG MEDICINE (000963.SZ) | Buy......
26.09.25 - 07:15
Research: JPM Initiates Coverage on HANSOH PHARMA w/ Rating Overweight, TP HKD43 (AAStocks)
 
JPMorgan has released a research report initiating coverage on HANSOH PHARMA (03692.HK) with an Overweight rating and a target price of HKD43 based on discounted cash flow analysis.According to the report, HANSOH PHARMA has transformed into an innovation-driven leader in recent years, with the contribution from innovative produc......
19.09.25 - 10:54
Chinese biotechs get a shot in the arm from policy support, licensing deals (SCMP)
 
Chinese biopharmaceutical stocks have become extremely popular with investors this year amid strong policy support and a rise in licensing deals with multinational companies. A more than 100 per cent gain in the Hang Seng innovative drug index this year is an indication of the euphoria sweeping the sector. Key industry players such as Hansoh Pharmaceutical Group and WuXi Biologics, which are also members of the Hang Seng Index, have more than doubled year to date. The trade is reminiscent of the......
18.09.25 - 23:42
XFRA: DIVIDEND/INTEREST INFORMATION - 22.09.2025 - KYG549581067 (XETRA)
 
Das Instrument 3KY KYG549581067 HANSOH PHARMAC. HD-,00001 EQUITY wird cum Dividende/Zinsen gehandelt am 19.09.2025 und ex Dividende/Zinsen am 22.09.2025 The instrument 3KY KYG549581067 HANSOH PHARMAC. HD-,00001 EQUITY has its pre-dividend/interest day on 19.09.2025 and its ex-dividend/interest day on 22.09.2025...
16.09.25 - 04:30
TRANSTHERA-B Once Leaps 64% in Early Trading, Soaring 50x in Less Than 3 Mths Since Debut, Surpassing HANSOH PHARMA in Mkt Cap (AAStocks)
 
TRANSTHERA-B (02617.HK), a semi-IPO that has been on a sharp uptrend in recent days, opened 15% higher this morning (16th) and once surged by 63.7% in early trading to a new high of HKD679.5, which, compared to its listing price of HKD13.15 on June 23, 2025, marked a spike of nearly 50.7 times in less than three months. It last ......
12.09.25 - 04:45
Research: HSBC Research Positive on LT Growth of CN Biotech, Favors INNOVENT BIO/ HANSOH PHARMA (AAStocks)
 
HSBC Global Research's report said that the White House is reportedly drafting a proposal that may affect the external licensing business development between Chinese generic and innovative drugs companies and U.S. companies. Although specific details have not been released, the related policy may involve stricter scrutiny on......
20.08.25 - 09:00
Research: CLSA Lifts TPs for HANSOH PHARMA, CMS on Expectations of Continued Growth for Pharmas (AAStocks)
 
Three Chinese pharma companies, SINO BIOPHARM (01177.HK), HANSOH PHARMA (03692.HK), and CMS (00867.HK), recorded solid results for 1H25 and achieved double-digit revenue growth in both 2H25 and 1H25, according to a research report by CLSA.In the broker's estimate, their momentum will persist into 2H25 on tailwinds such as th......
20.08.25 - 06:30
Midday Takeaway: HSI Closes Midday at 24,980, Down 142 pts; HSTI Closes Midday at 5,472, Down 69 pts; HANSOH PHARMA Down over 7%; FUYAO GLASS, POP MART, CHINAGOLDINTL, KLN, YUEXIUTRANSPORT Hit New Highs (AAStocks)
 
At midday close, HSI dropped 142 pts or 0.6% to 24,980. HSTI dropped 69 pts or 1.3% to 5,472. HSCEI fell 60 pts or 0.7% to 8,945.Active Heavyweights:BABA (09988.HK) closed at $116.4, down 1.6%TENCENT (00700.HK) closed at $587.5, down 0.8%MEITUAN (03690.HK) closed at $120, down 0.7%XIAOMI (01810.HK) closed at $52.25, down 0.3%HSI......
20.08.25 - 05:00
Research: BOCOMI Adds HANSOH PHARMA's TP to HKD48; Rating Kept Buy (AAStocks)
 
Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...
20.08.25 - 04:15
HANSOH PHARMA Opens ~5% Lower, Raises $3.9B from Shr Placement at 6.5% Discount (AAStocks)
 
Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...
20.08.25 - 03:30
HANSOH PHARMA Places Shrs at 6.5% Discount, Raising Net ~$3.9B (AAStocks)
 
HANSOH PHARMA (03692.HK) announced the placement of 108 million shares of the company, representing approximately 1.78% of the enlarged share capital, at a price of HKD36.3 per share, which was about a 6.49% discount to yesterday's (19th) closing price of HKD38.82.The company expected to raise net proceeds of approximately H......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wer der Folter erlag, kann nicht mehr heimisch werden auf dieser Welt. - Jean Améry
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!